Drug Profile
Albumin-bound paclitaxel/JO 1
Alternative Names: JO-1/nab-paclitaxelLatest Information Update: 28 Oct 2018
Price :
$50
*
At a glance
- Originator PAI Life Sciences
- Class Drug conjugates
- Mechanism of Action Tight junction protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Ovarian cancer
Most Recent Events
- 28 Oct 2018 No recent reports of development identified for research development in Ovarian-cancer in USA (Parenteral, Injection)